203 related articles for article (PubMed ID: 28038817)
1. Low partial pressure of end-tidal carbon dioxide predicts left ventricular assist device implantation in patients with advanced chronic heart failure.
Seguchi O; Hisamatsu E; Nakano A; Nakajima S; Kuroda K; Watanabe T; Sato T; Sunami H; Yanase M; Hata H; Hamasaki T; Fujita T; Kobayashi J; Nakatani T; Kitakaze M; Fukushima N
Int J Cardiol; 2017 Mar; 230():40-46. PubMed ID: 28038817
[TBL] [Abstract][Full Text] [Related]
2. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
[TBL] [Abstract][Full Text] [Related]
3. INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure.
Stewart GC; Kittleson MM; Patel PC; Cowger JA; Patel CB; Mountis MM; Johnson FL; Guglin ME; Rame JE; Teuteberg JJ; Stevenson LW
Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27834198
[TBL] [Abstract][Full Text] [Related]
4. The partial pressure of resting end-tidal carbon dioxide predicts major cardiac events in patients with systolic heart failure.
Arena R; Myers J; Abella J; Pinkstaff S; Brubaker P; Moore B; Kitzman D; Peberdy MA; Bensimhon D; Chase P; Guazzi M
Am Heart J; 2008 Nov; 156(5):982-8. PubMed ID: 19061716
[TBL] [Abstract][Full Text] [Related]
5. Use of left ventricular assist device (HeartMate II): a Singapore experience.
Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
[TBL] [Abstract][Full Text] [Related]
6. Decoupling Between Diastolic Pulmonary Artery Pressure and Pulmonary Capillary Wedge Pressure as a Prognostic Factor After Continuous Flow Ventricular Assist Device Implantation.
Imamura T; Chung B; Nguyen A; Rodgers D; Sayer G; Adatya S; Sarswat N; Kim G; Raikhelkar J; Ota T; Song T; Juricek C; Kagan V; Jeevanandam V; Mehra M; Burkhoff D; Uriel N
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912260
[TBL] [Abstract][Full Text] [Related]
7. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices.
Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP
Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic Assessment of Patients With and Without Heart Failure Symptoms Supported by a Continuous-Flow Left Ventricular Assist Device.
Asleh R; Hasin T; Briasoulis A; Schettle SD; Borlaug BA; Behfar A; Pereira NL; Edwards BS; Clavell AL; Joyce LD; Maltais S; Stulak JM; Kushwaha SS
Mayo Clin Proc; 2018 Jul; 93(7):895-903. PubMed ID: 29891343
[TBL] [Abstract][Full Text] [Related]
9. Assessment of right ventricular dysfunction predictors before the implantation of a left ventricular assist device in end-stage heart failure patients using echocardiographic measures (ARVADE): Combination of left and right ventricular echocardiographic variables.
Aissaoui N; Salem JE; Paluszkiewicz L; Morshuis M; Guerot E; Gorria GM; Fagon JY; Gummert J; Diebold B
Arch Cardiovasc Dis; 2015 May; 108(5):300-9. PubMed ID: 25863429
[TBL] [Abstract][Full Text] [Related]
10. Outcomes with ambulatory advanced heart failure from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry.
Ambardekar AV; Kittleson MM; Palardy M; Mountis MM; Forde-McLean RC; DeVore AD; Pamboukian SV; Thibodeau JT; Teuteberg JJ; Cadaret L; Xie R; Taddei-Peters W; Naftel DC; Kirklin JK; Stevenson LW; Stewart GC
J Heart Lung Transplant; 2019 Apr; 38(4):408-417. PubMed ID: 30948210
[TBL] [Abstract][Full Text] [Related]
11. High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry.
Ambardekar AV; Forde-McLean RC; Kittleson MM; Stewart GC; Palardy M; Thibodeau JT; DeVore AD; Mountis MM; Cadaret L; Teuteberg JJ; Pamboukian SV; Cantor RS; Lindenfeld J
J Heart Lung Transplant; 2016 Jun; 35(6):722-30. PubMed ID: 26987599
[TBL] [Abstract][Full Text] [Related]
12. Cavoaortic shunt improves hemodynamics with preserved oxygen delivery in experimental right ventricular failure during left ventricular assist device therapy.
Vikholm P; Schiller P; Johansson J; Hellgren L
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):625-31. PubMed ID: 23477692
[TBL] [Abstract][Full Text] [Related]
13. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
[TBL] [Abstract][Full Text] [Related]
14. Myocardial Recovery in Patients Receiving Contemporary Left Ventricular Assist Devices: Results From the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS).
Topkara VK; Garan AR; Fine B; Godier-Furnémont AF; Breskin A; Cagliostro B; Yuzefpolskaya M; Takeda K; Takayama H; Mancini DM; Naka Y; Colombo PC
Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27402861
[TBL] [Abstract][Full Text] [Related]
15. Liver stiffness measurements and short-term survival after left ventricular assist device implantation: A pilot study.
Potthoff A; Schettler A; Attia D; Schlue J; Schmitto JD; Fegbeutel C; Strüber M; Haverich A; Manns MP; Wedemeyer H; Gebel M; Schneider A
J Heart Lung Transplant; 2015 Dec; 34(12):1586-94. PubMed ID: 26169664
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary Bleeding During Right Ventricular Support After Left Ventricular Assist Device Implantation.
Welp H; Sindermann JR; Deschka H; Martens S; Scherer M
J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):627-31. PubMed ID: 26460277
[TBL] [Abstract][Full Text] [Related]
17. Fine-tuning management of the Heart Assist 5 left ventricular assist device with two- and three-dimensional echocardiography.
Demirozu ZT; Arat N; Kucukaksu DS
Cardiovasc J Afr; 2016; 27(4):208-212. PubMed ID: 27841907
[TBL] [Abstract][Full Text] [Related]
18. B-Type Natriuretic Peptide Levels Predict Ventricular Arrhythmia Post Left Ventricular Assist Device Implantation.
Hellman Y; Malik AS; Lin H; Shen C; Wang IW; Wozniak TC; Hashmi ZA; Pickrell J; Jani M; Caccamo MA; Gradus-Pizlo I; Hadi A
Artif Organs; 2015 Dec; 39(12):1051-5. PubMed ID: 25864448
[TBL] [Abstract][Full Text] [Related]
19. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
[TBL] [Abstract][Full Text] [Related]
20. From bench to bedside: Can the improvements in left ventricular assist device design mitigate adverse events and increase survival?
Tarzia V; Di Giammarco G; Di Mauro M; Bortolussi G; Maccherini M; Tursi V; Maiani M; Bernazzali S; Marinelli D; Foschi M; Buratto E; Bejko J; Gregori D; Scuri S; Livi U; Sani G; Bottio T; Gerosa G
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):213-7. PubMed ID: 26548997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
